>
Fa
|
Ar
|
En
protein and cell
سال:2018 - دوره:9 - شماره:1
a novel therapeutic anti-hbv antibody with increased binding to human fcrn improves in vivo pk in mice and monkeys
- صفحه:130-134
antibody-drug conjugates: recent advances in conjugation and linker chemistries
- صفحه:33-46
current progress in innovative engineered antibodies
- صفحه:86-120
distinct pd-l1 binding characteristics of therapeutic monoclonal antibody durvalumab
- صفحه:135-139
glycosylation engineering of therapeutic igg antibodies: challenges for the safety, functionality and efficacy
- صفحه:47-62
igg fc engineering to modulate antibody effector functions
- صفحه:63-73
in vitro-engineered non-antibody protein therapeutics
- صفحه:3-14
molecular and functional analysis of monoclonal antibodies in support of biologics development
- صفحه:74-85
pharmacokinetics of monoclonal antibodies and fc-fusion proteins
- صفحه:15-32
potent and conditional redirected t cell killing of tumor cells using half dvd-ig
- صفحه:121-129
“magic bullets” at the center stage of immune therapy: a special issue on therapeutic antibodies
Copyright 2023
Islamic World Science Citation Center
All Rights Reserved
